Both in Biotechnology
Scribe Therapeutics vs Agenus
Over the past year SCTX returned −48.2% and AGEN returned −1.4%; their daily moves had a correlation of 0.15.
SCTX −48.2% AGEN −1.4%Growth of $1, one year, split-adjusted
| Metric | SCTX | AGEN |
|---|---|---|
| Price | $15.42 | $6.84 |
| Market cap | $291.9M | $308.9M |
| Today | −11.58% | −3.53% |
| 1 month | −10.2% | −17.9% |
| 6 months | — | +78.1% |
| Year to date | — | +117.8% |
| 1 year | — | +77.7% |
| Revenue growth (YoY) | — | +34.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1.7% |
| P/E (TTM) | — | 3.4× |
| Price / sales | — | 2.3× |
| Net cash | — | -$11.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 89.2% |
| Short % of float | 14.6% | 16.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).